A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours)

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522913-45-00

Enrollment

Registered

2026-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced relapsed or refractory endometrial cancer, Advanced relapsed or refractory germ cell tumours, Advanced relapsed or refractory ovarian cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

None listed

Source: EU CTIS · Data processed: Apr 21, 2026